Agile Therapeutics Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 28
Employees
  • Stock Symbol
  • AGRX
Stock Symbol
  • Share Price
  • $1.41
  • (As of Friday Closing)

Agile Therapeutics General Information

Description

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 101 Poor Farm Road
  • Princeton, NJ 08540
  • United States

Agile Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Agile Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.41 $1.45 $1.28 - $3.89 $124M 88.3M 1.1M -$0.70

Agile Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 144,316 198,169 130,097 8,777
Revenue 865 749 0 0
EBITDA (56,880) (48,777) (18,695) (19,483)
Net Income (61,098) (51,853) (18,606) (19,779)
Total Assets 59,477 73,062 49,540 22,392
Total Debt 19,347 16,519 172 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Agile Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Agile Therapeutics‘s full profile, request access.

Request a free trial

Agile Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Agile Therapeutics‘s full profile, request access.

Request a free trial

Agile Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidate
Pharmaceuticals
Princeton, NJ
28 As of 2020
00000
000000 - 000 00000

000000 0

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
000000000000000
San Diego, CA
000 As of 0000
00000
0000000000 0 00000

000000 0

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
0000 000000000
South San Francisco, CA
00 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Agile Therapeutics Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Suneva Medical Venture Capital-Backed San Diego, CA 000 00000 0000000000 0 00000
000000 00000000000 Private Equity-Backed South San Francisco, CA 00 00000 0000000 0000 00000
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000 0000
00000 000000000000 Formerly PE-Backed Mumbai, India 00000 00000 00000000 00000
00 000000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000&0 00000
You’re viewing 5 of 20 competitors. Get the full list »

Agile Therapeutics Executive Team (14)

Name Title Board Seat Contact Info
Alfred Altomari Chief Executive Officer & Chairman
Dennis Reilly Chief Financial Officer, Finance & Senior Vice President
Robert Conway Executive & Senior Vice President
Geoffrey Gilmore JD General Counsel, Legal & Secretary, Administration
Paul Korner Chief Medical Officer & Senior Vice President
You’re viewing 5 of 14 executive team members. Get the full list »

Agile Therapeutics Board Members (18)

Name Representing Role Since
Abhijeet Lele Self Board Member 000 0000
Ajit Shetty Ph.D Self Board Member 000 0000
Alfred Altomari Agile Therapeutics Chief Executive Officer & Chairman 000 0000
Gregory Arnold Agile Therapeutics Vice Chairman, Manufacturing 000 0000
James Tursi MD Self Board Member 000 0000
You’re viewing 5 of 18 board members. Get the full list »

Agile Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Agile Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Agile Therapeutics‘s full profile, request access.

Request a free trial